Multiple Myeloma

Edit Answers
123456789
Across
  1. 2. trial that showed benefit of daratumumab in addition to RVd in transplant eligible NDMM patients
  2. 3. What complication related to bony manifestations in multiple myeloma should be monitored?
  3. 5. criteria used to assess need for thromboprophylaxis in MM
  4. 7. trial that showed benefit of daratumumab in addition to CyBOrD
  5. 8. Which medication commonly used in multiple myeloma can interfere with cross-matching and red blood cell antibody screening?
  6. 9. The only oral proteasome inhibitor
Down
  1. 1. Standard regimen for active multiple myeloma
  2. 4. Which medication is typically used in high-dose therapy?
  3. 6. proteasome inhibitor that can potentially cause cardiac, renal, and pulmonary toxicities